Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3446)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
506
Price
$507.68
Total Value
$256.88K
Shares Held After
324,643
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
794
Price
$506.84
Total Value
$402.43K
Shares Held After
325,149
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
875
Price
$505.78
Total Value
$442.56K
Shares Held After
325,943
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
964
Price
$505.03
Total Value
$486.85K
Shares Held After
326,818
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,144
Price
$503.60
Total Value
$576.12K
Shares Held After
327,782
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,017
Price
$502.87
Total Value
$511.41K
Shares Held After
328,926
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
361
Price
$500.84
Total Value
$180.80K
Shares Held After
329,943
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
519
Price
$499.73
Total Value
$259.36K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$498.85
Total Value
$199.54K
Shares Held After
330,823
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$497.56
Total Value
$79.61K
Shares Held After
331,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,278
Price
$496.73
Total Value
$634.82K
Shares Held After
331,383
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$495.65
Total Value
$595.77K
Shares Held After
332,661
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$493.81
Total Value
$39.50K
Shares Held After
333,863
% of Holdings
0.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
3,100
Price
$3.93
Total Value
$12.18K
Shares Held After
11,245,631
% of Holdings
0.0%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
6
Price
$13.60
Total Value
$81.62
Shares Held After
16,246
% of Holdings
0.0%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
3,149
Price
$16.85
Total Value
$53.06K
Shares Held After
81,794
% of Holdings
3.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,836
Price
$2.09
Total Value
$12.20K
Shares Held After
2,775,229
% of Holdings
0.2%
Grace Therapeutics, Inc. (GRCE)
Kohli Prashant — Director
Shares
100,000
Price
$2.14
Total Value
$214.00K
Shares Held After
121,357
% of Holdings
82.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
1,334
Price
$59.52
Total Value
$79.40K
Shares Held After
145,435
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
36,000
Price
$97.78
Total Value
$3.52M
Shares Held After
708,709
% of Holdings
4.8%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
4,465,014
% of Holdings
2.2%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
54,174
Price
$145.87
Total Value
$7.90M
Shares Held After
522,968
% of Holdings
9.4%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
20,000
Price
$39.90
Total Value
$798.00K
Shares Held After
42,963
% of Holdings
31.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
9,989
Price
$25.03
Total Value
$249.99K
Shares Held After
116,182
% of Holdings
7.9%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$115.14
Total Value
$57.57K
Shares Held After
9,500
% of Holdings
5.0%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
371
Price
$212.27
Total Value
$78.75K
Shares Held After
0
% of Holdings
100.0%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
3,844
Price
$211.36
Total Value
$812.46K
Shares Held After
371
% of Holdings
91.2%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
4,730
Price
$210.50
Total Value
$995.68K
Shares Held After
4,215
% of Holdings
52.9%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
2,853
Price
$209.56
Total Value
$597.87K
Shares Held After
8,945
% of Holdings
24.2%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
3,587
Price
$208.55
Total Value
$748.08K
Shares Held After
11,798
% of Holdings
23.3%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
999
Price
$207.33
Total Value
$207.12K
Shares Held After
15,385
% of Holdings
6.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
706
Price
$206.60
Total Value
$145.86K
Shares Held After
16,384
% of Holdings
4.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
22,408
Price
$3.52
Total Value
$78.82K
Shares Held After
2,072,890
% of Holdings
1.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
6,278
Price
$351.25
Total Value
$2.21M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
6,569
Price
$350.27
Total Value
$2.30M
Shares Held After
6,278
% of Holdings
51.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
10,688
Price
$349.28
Total Value
$3.73M
Shares Held After
12,847
% of Holdings
45.4%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
7,492
Price
$348.31
Total Value
$2.61M
Shares Held After
23,535
% of Holdings
24.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,721
Price
$348.01
Total Value
$598.93K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,517
Price
$347.39
Total Value
$526.99K
Shares Held After
1,721
% of Holdings
46.8%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
2,841
Price
$346.16
Total Value
$983.43K
Shares Held After
3,238
% of Holdings
46.7%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,181
Price
$345.38
Total Value
$407.90K
Shares Held After
6,079
% of Holdings
16.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,442
Price
$23.43
Total Value
$80.66K
Shares Held After
181,641
% of Holdings
1.9%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
14,058
Price
$22.77
Total Value
$320.05K
Shares Held After
185,083
% of Holdings
7.1%
Jazz Pharmaceuticals plc (JAZZ)
GALA RENEE D — President&CEO
Shares
2,000
Price
$243.03
Total Value
$486.06K
Shares Held After
143,394
% of Holdings
1.4%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
7,347
Price
$13.51
Total Value
$99.29K
Shares Held After
16,252
% of Holdings
31.1%
Showing 201–250 of 3446 transactions (page 5 of 69)